We have updated forecasts post H1 2016 results and to reflect both the discontinued nature of Sinclair’s non-aesthetics business and the recent early settlement of contingent Ellansé milestones. Although the company’s destocking initiative and (now largely resolved) distribution issues in South Korea impacted H1 performance to a higher extent than we anticipated, we are encouraged by the in-market sales performance of core aesthetics products Silhouette (+64% YoY in H1), Ellansé® (+100%), Perfec ....
